' '
Deutsch | English    

Research Database PMU-SQQUID

Publications

chosen keywordprostate cancer


Prostate-specific membrane antigen radioligand therapy of prostate cancer.
Beheshti, M; Heinzel, A; von Mallek, D; Filss, C; Mottaghy, FM
Q J Nucl Med Mol Imaging. 2019; 63(1):29-36
Übersichtsarbeiten
Indocyanine green fluorescence-guided sentinel lymph node identification in urologic cancers: a systematic review and meta-analysis.
Aoun, F; Albisinni, S; Zanaty, M; Hassan, T; Janetschek, G; van Velthoven, R
MINERVA UROL NEFROL. 2018; 70(4): 361-369.
Übersichtsarbeiten
Optimal time-point for
Beheshti, M; Paymani, Z; Brilhante, J; Geinitz, H; Gehring, D; Leopoldseder, T; Wouters, L; Pirich, C; Loidl, W; Langsteger, W
EUR J NUCL MED MOL I. 2018; 45(7): 1188-1196.
Originalarbeiten (Zeitschrift)
Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
Ghadjar, P; Aebersold, DM; Albrecht, C; Böhmer, D; Flentje, M; Ganswindt, U; Höcht, S; Hölscher, T; Sedlmayer, F; Wenz, F; Zips, D; Wiegel, T;
Strahlenther Onkol. 2018; 194(7): 619-626.
Originalarbeiten (Zeitschrift)
Texture analysis of apparent diffusion coefficient maps for treatment response assessment in prostate cancer bone metastases-A pilot study.
Reischauer, C; Patzwahl, R; Koh, DM; Froehlich, JM; Gutzeit, A
EUR J RADIOL. 2018; 101: 184-190.
Originalarbeiten (Zeitschrift)
Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer.
Sevcenco, S; Klingler, HC; Eredics, K; Friedl, A; Schneeweiss, J; Knoll, P; Kunit, T; Lusuardi, L; Mirzaei, S
ADV THER. 2018; 35(6): 779-784.
Originalarbeiten (Zeitschrift)
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach
Conti, A; D'Elia, C; Cheng, M; Santoni, M; Piva, F; Brunelli, M; Lopez-Beltran, A; Giulietti, M; Scarpelli, M; Pycha, A; Galosi, AB; Artibani, W; Cheng, L; Montironi, R; Battelli, N; Lusuardi, L
EUR UROL SUPPL. 2017; 16(12): 309-315.
Originalarbeiten (Zeitschrift)
Therapy assessment of bone metastatic disease in the era of (223)radium
Etchebehere, E; Brito, AE; Rezaee, A; Langsteger, W; Beheshti, M
EUR J NUCL MED MOL I. 2017; 44: S84-S96.
Übersichtsarbeiten
Prostate-specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction With the In-bore 3-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy After Negative 12-Core Biopsy.
Friedl, A; Stangl, K; Bauer, W; Kivaranovic, D; Schneeweiss, J; Susani, M; Hruby, S; Lusuardi, L; Lomoschitz, F; Eisenhuber-Stadler, E; Schima, W; Brössner, C;
Urology. 2017; 110: 148-153.
Originalarbeiten (Zeitschrift)
Hypofractionated radiotherapy for localized prostate cancer.
Höcht, S; Aebersold, DM; Albrecht, C; Böhmer, D; Flentje, M; Ganswindt, U; Hölscher, T; Martin, T; Sedlmayer, F; Wenz, F; Zips, D; Wiegel, T;
Strahlenther Onkol. 2017; 193(1): 1-12.
Übersichtsarbeiten
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
Radtke, JP; Wiesenfarth, M; Kesch, C; Freitag, MT; Alt, CD; Celik, K; Distler, F; Roth, W; Wieczorek, K; Stock, C; Duensing, S; Roethke, MC; Teber, D; Schlemmer, HP; Hohenfellner, M; Bonekamp, D; Hadaschik, BA;
Eur Urol. 2017; 72(6): 888-896.
Originalarbeiten (Zeitschrift)
Non-Mono-Exponential Analysis of Diffusion-Weighted Imaging for Treatment Monitoring in Prostate Cancer Bone Metastases
Reischauer, C; Patzwahl, R; Koh, DM; Froehlich, JM; Gutzeit, A;
SCI REP-UK. 2017; 7: 5809
Originalarbeiten (Zeitschrift)
Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy.
Wit, EM; Acar, C; Grivas, N; Yuan, C; Horenblas, S; Liedberg, F; Valdes Olmos, RA; van Leeuwen, FW; van den Berg, NS; Winter, A; Wawroschek, F; Hruby, S; Janetschek, G; Vidal-Sicart, S; MacLennan, S; Lam, TB; van der Poel, HG;
Eur Urol. 2017; 71(4):596-605
Übersichtsarbeiten
Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers.
Zschabitz, S; Vallet, S; Hadaschik, B; Debatin, D; Fuxius, S; Karcher, A; Pahernik, S; Spath, C; Duensing, S; Jager, D; Hohenfellner, M; Grullich, C
J CANCER. 2017; 8(4): 507-512.
Originalarbeiten (Zeitschrift)
Evaluation of Prostate Cancer Bone Metastases with F-18-NaF and F-18-Fluorocholine PET/CT
Beheshti, M; Rezaee, A; Geinitz, H; Loidl, W; Pirich, C; Langsteger, W
J NUCL MED. 2016; 57: 55S-60S.
Originalarbeiten (Zeitschrift)
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin, JL; Billia, M; Relle, J; Roethke, MC; Popeneciu, IV; Kuru, TH; Hatiboglu, G; Mueller-Wolf, MB; Motsch, J; Romagnoli, C; Kassam, Z; Harle, CC; Hafron, J; Nandalur, KR; Chronik, BA; Burtnyk, M; Schlemmer, HP; Pahernik, S;
Eur Urol. 2016; 70(3): 447-455.
Originalarbeiten (Zeitschrift)
[Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
Distler, F; Radtke, JP; Kesch, C; Roethke, M; Schlemmer, HP; Roth, W; Hohenfellner, M; Hadaschik, B
UROLOGE. 2016; 55(2): 146-155.
Originalarbeiten (Zeitschrift)
[Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
Kesch, C; Radtke, JP; Distler, F; Boxler, S; Klein, T; Huttenbrink, C; Hees, K; Roth, W; Roethke, M; Schlemmer, HP; Hohenfellner, M; Hadaschik, BA
UROLOGE. 2016; 55(8): 1071-1077.
Originalarbeiten (Zeitschrift)
(18)F-NaF-PET/CT and (99m)Tc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.
Langsteger, W; Rezaee, A; Pirich, C; Beheshti, M;
Semin Nucl Med. 2016; 46(6): 49-501.
Übersichtsarbeiten
The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1.
Luef, B; Handle, F; Kharaishvili, G; Hager, M; Rainer, J; Janetschek, G; Hruby, S; Englberger, C; Bouchal, J; Santer, FR; Culig, Z;
Endocr Relat Cancer. 2016; 23(6): 495-508.
Originalarbeiten (Zeitschrift)
Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer.
Ponholzer, A; Loidl, W; Bektic, J; Dorfinger, K; Hruby, S; Jeschke, K; Kramer, G; Krause, S; Ludvik, G; Remzi, M; Roider, M; Stoiber, F;
Wien Klin Wochenschr. 2016; 128(3-4):156-163
Originalarbeiten (Zeitschrift)
Pilot study on the detection of antiandrogen resistance using serial diffusion-weighted imaging of bone metastases in prostate cancer.
Reischauer, C; Koh, DM; Froehlich, JM; Patzwahl, R; Binkert, CA; Gutzeit, A;
J Magn Reson Imaging. 2016; 43(6): 1407-1416.
Originalarbeiten (Zeitschrift)
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Beheshti, M; Kunit, T; Haim, S; Zakavi, R; Schiller, C; Stephens, A; Dinkelborg, L; Langsteger, W; Loidl, W;
Mol Imaging Biol. 2015; 17(3):424-433
Originalarbeiten (Zeitschrift)
Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt, PF; Seklehner, S; Brustmann, H; Lusuardi, L; Riedl, CR;
Scand J Urol. 2015; 49(2):120-126
Originalarbeiten (Zeitschrift)
The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance.
Hermann-Kleiter, N; Klepsch, V; Wallner, S; Siegmund, K; Klepsch, S; Tuzlak, S; Villunger, A; Kaminski, S; Pfeifhofer-Obermair, C; Gruber, T; Wolf, D; Baier, G
CELL REP. 2015; 12(12): 2072-2085.
Originalarbeiten (Zeitschrift)
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Höfner, T; Vallet, S; Hadaschik, BA; Pahernik, S; Duensing, S; Hohenfellner, M; Jäger, D; Grüllich, C;
World J Urol. 2015; 33(6): 833-839.
Originalarbeiten (Zeitschrift)
Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
Hruby, S; Englberger, C; Lusuardi, L; Schätz, T; Kunit, T; Abdel-Aal, AM; Hager, M; Janetschek, G;
J Urol. 2015; 194(2):357-363
Originalarbeiten (Zeitschrift)
Editorial comment on "Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer".
Janetschek, G; Hruby, S;
Scand J Urol. 2015; 49(1):77-78
Editorials
Identification of cell-free microRNAs in the urine of patients with prostate cancer.
Korzeniewski, N; Tosev, G; Pahernik, S; Hadaschik, B; Hohenfellner, M; Duensing, S;
Urol Oncol. 2015; 33(1): 16.e17-16.e22.
Originalarbeiten (Zeitschrift)
Focal therapy of prostate cancer
Pahernik, S; Hadaschik, B; Schlemmer, HP
ONKOLOGE. 2015; 21(9): 797-+.
Originalarbeiten (Zeitschrift)
A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment.
Thiruchelvam, N; Cruz, F; Kirby, M; Tubaro, A; Chapple, CR; Sievert, KD;
BJU Int. 2015; 116(6): 853-861.
Originalarbeiten (Zeitschrift)
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
Vali, R; Loidl, W; Pirich, C; Langesteger, W; Beheshti, M;
Am J Nucl Med Mol Imaging. 2015; 5(2): 96-108.
Übersichtsarbeiten
Evolving therapeutic concepts in prostate cancer based on genome-wide analyses (review).
Georgi, B; Korzeniewski, N; Hadaschik, B; Grüllich, C; Roth, W; Sültmann, H; Pahernik, S; Hohenfellner, M; Duensing, S;
Int J Oncol. 2014; 45(4): 1337-1344.
Übersichtsarbeiten
[Importance of complementary medicine approaches for patients with prostate cancer].
Gschwendtner, KM; Klein, G; Güthlin, C; Holmberg, C; Horneber, M; Weis, J;
Urologe A. 2014; 53(11): 1600-1609.
Originalarbeiten (Zeitschrift)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.
Kwon, ED; Drake, CG; Scher, HI; Fizazi, K; Bossi, A; van den Eertwegh, AJ; Krainer, M; Houede, N; Santos, R; Mahammedi, H; Ng, S; Maio, M; Franke, FA; Sundar, S; Agarwal, N; Bergman, AM; Ciuleanu, TE; Korbenfeld, E; Sengeløv, L; Hansen, S; Logothetis, C; Beer, TM; McHenry, MB; Gagnier, P; Liu, D; Gerritsen, WR;
Lancet Oncol. 2014; 15(7): 700-712.
Originalarbeiten (Zeitschrift)
Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.
van den Bos, W; Muller, BG; Ahmed, H; Bangma, CH; Barret, E; Crouzet, S; Eggener, SE; Gill, IS; Joniau, S; Kovacs, G; Pahernik, S; de la Rosette, JJ; Rouvière, O; Salomon, G; Ward, JF; Scardino, PT;
Eur Urol. 2014; 65(6):107-183
Originalarbeiten (Zeitschrift)
Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti, M; Haim, S; Zakavi, R; Steinmair, M; Waldenberger, P; Kunit, T; Nader, M; Langsteger, W; Loidl, W;
J Nucl Med. 2013; 54(6): 833-840.
Originalarbeiten (Zeitschrift)
Clinical and technical characteristics of intraoperative radiotherapy : Analysis of the ISIORT-Europe database.
Krengli, M; Calvo, FA; Sedlmayer, F; Sole, CV; Fastner, G; Alessandro, M; Maluta, S; Corvò, R; Sperk, E; Litoborski, M; Pisani, C; Fillini, C; Fusconi, F; Osti, MF; Tomio, L; Marsiglia, H; Ciabattoni, A; Polkowski, W; Di Grazia, A; Gava, A; Kuten, A; Iotti, C; Gonzalez, C; Sallabanda, M; Dubois, JB; Catalano, G; Valentini, V;
Strahlenther Onkol. 2013; 189(9): 729-737.
Originalarbeiten (Zeitschrift)
Psychological stress assessment of patients suffering from prostate cancer.
Seklehner, S; Hladschik-Kermer, B; Lusuardi, L; Schabauer, C; Riedl, C; Engelhardt, PF;
Scand J Urol. 2013; 47(2):101-107
Originalarbeiten (Zeitschrift)
PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapy.
Hofner, T; Pfitzenmaier, J; Alrabadi, A; Pahernik, S; Hadaschik, B; Wagener, N; Djakovic, N; Haferkamp, A; Hohenfellner, M;
World J Urol. 2012; 30(1):91-95
Originalarbeiten (Zeitschrift)
Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment.
Horneber, M; Fischer, I; Dimeo, F; Rüffer, JU; Weis, J;
Dtsch Arztebl Int. 2012; 109(9): 161-171.
Originalarbeiten (Zeitschrift)
[Integrative aspects of thoracic oncology].
Horneber, M; Mehnert, A; Roser, T; Rostock, M;
Onkologie. 2012; 35 Suppl 3: 2-5.
Originalarbeiten (Zeitschrift)
Patients" view of their preoperative education for radical prostatectomy: does it change after surgery?
Huber, J; Ihrig, A; Herzog, W; Huber, CG; Konyango, B; Löser, E; Hatiboglu, G; Hadaschik, BA; Pahernik, S; Hohenfellner, M;
J Cancer Educ. 2012; 27(2):377-382
Originalarbeiten (Zeitschrift)
Imaging of bone metastases in prostate cancer: an update.
Langsteger, W; Haim, S; Knauer, M; Waldenberger, P; Emmanuel, K; Loidl, W; Wolf, I; Beheshti, M;
Q J Nucl Med Mol Imaging. 2012; 56(5):447-458
Übersichtsarbeiten
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
Rick, FG; Schally, AV; Szalontay, L; Block, NL; Szepeshazi, K; Nadji, M; Zarandi, M; Hohla, F; Buchholz, S; Seitz, S;
Proc Natl Acad Sci U S A. 2012; 109(5):1655-1660
Originalarbeiten (Zeitschrift)
Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler, J; Weöres, I; Brinkschmidt, C; Zeitler, H; Panzer, S; Scharf, M; Heuck, A; Siebels, M;
Rofo. 2012; 184(2):130-135
Originalarbeiten (Zeitschrift)
Genitourinary applications of diffusion-weighted MR imaging in the pelvis.
Thoeny, HC; Forstner, R; De Keyzer, F
Radiology. 2012; 263(2):326-342
Übersichtsarbeiten
Impact of clinical parameters on the diagnostic accuracy of endorectal coil MRI for the detection of prostate cancer.
Colleselli, D; Hennenlotter, J; Schilling, D; Krueger, SA; Roethke, M; Lichy, MP; Vogel, U; Kuehs, U; Schlemmer, HP; Stenzl, A; Schwentner, C;
Urol Int. 2011; 86(4): 393-398.
Originalarbeiten (Zeitschrift)
Delayed detection of injury to an ectopic ureter of a duplicated collecting system following laparoscopic radical prostatectomy for early organ-confined prostate cancer.
Ghazi, A; Zimmermann, R; Janetschek, G;
UROL INT. 2011; 86(1): 121-124.
Originalarbeiten (Zeitschrift)
[Patient centeredness and decision-making in localised prostate cancer: possible fields of health services research in urology].
Huber, J; Ihrig, A; Huber, CG; Hadaschik, B; Pahernik, S; Hohenfellner, M;
Urologe A. 2011; 50(6):691-696
Originalarbeiten (Zeitschrift)
Decision-making in localized prostate cancer: lessons learned from an online support group.
Huber, J; Ihrig, A; Peters, T; Huber, CG; Kessler, A; Hadaschik, B; Pahernik, S; Hohenfellner, M;
BJU Int. 2011; 107(10):1570-1575
Originalarbeiten (Zeitschrift)
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
Langsteger, W; Balogova, S; Huchet, V; Beheshti, M; Paycha, F; Egrot, C; Janetschek, G; Loidl, W; Nataf, V; Kerrou, K; Pascal, O; Cussenot, O; Talbot, JN;
Q J Nucl Med Mol Imaging. 2011; 55(4): 448-457.
Originalarbeiten (Zeitschrift)
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].
Moehler, M; Al-Batran, SE; Andus, T; Anthuber, M; Arends, J; Arnold, D; Aust, D; Baier, P; Baretton, G; Bernhardt, J; Boeing, H; Böhle, E; Bokemeyer, C; Bornschein, J; Budach, W; Burmester, E; Caca, K; Diemer, WA; Dietrich, CF; Ebert, M; Eickhoff, A; Ell, C; Fahlke, J; Feussner, H; Fietkau, R; Fischbach, W; Fleig, W; Flentje, M; Gabbert, HE; Galle, PR; Geissler, M; Gockel, I; Graeven, U; Grenacher, L; Gross, S; Hartmann, JT; Heike, M; Heinemann, V; Herbst, B; Herrmann, T; Höcht, S; Hofheinz, RD; Höfler, H; Höhler, T; Hölscher, AH; Horneber, M; Hübner, J; Izbicki, JR; Jakobs, R; Jenssen, C; Kanzler, S; Keller, M; Kiesslich, R; Klautke, G; Körber, J; Krause, BJ; Kuhn, C; Kullmann, F; Lang, H; Link, H; Lordick, F; Ludwig, K; Lutz, M; Mahlberg, R; Malfertheiner, P; Merkel, S; Messmann, H; Meyer, HJ; Mönig, S; Piso, P; Pistorius, S; Porschen, R; Rabenstein, T; Reichardt, P; Ridwelski, K; Röcken, C; Roetzer, I; Rohr, P; Schepp, W; Schlag, PM; Schmid, RM; Schmidberger, H; Schmiegel, WH; Schmoll, HJ; Schuch, G; Schuhmacher, C; Schütte, K; Schwenk, W; Selgrad, M; Sendler, A; Seraphin, J; Seufferlein, T; Stahl, M; Stein, H; Stoll, C; Stuschke, M; Tannapfel, A; Tholen, R; Thuss-Patience, P; Treml, K; Vanhoefer, U; Vieth, M; Vogelsang, H; Wagner, D; Wedding, U; Weimann, A; Wilke, H; Wittekind, C;
Z Gastroenterol. 2011; 49(4): 461-531.
Originalarbeiten (Zeitschrift)
Expression of the non-gastric H+/K+ ATPase ATP12A in normal and pathological human prostate tissue.
Streif, D; Iglseder, E; Hauser-Kronberger, C; Fink, KG; Jakab, M; Ritter, M;
Cell Physiol Biochem. 2011; 28(6):1287-1294
Originalarbeiten (Zeitschrift)
The impact of storage effects in biobanks on biomarker discovery in systems biology studies
Balasubramanian, R; Muller, L; Kugler, K; Hackl, W; Pleyer, L; Dehmer, M; Graber, A
BIOMARKERS. 2010; 15(8): 677-683.
Originalarbeiten (Zeitschrift)
18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
Beheshti, M; Imamovic, L; Broinger, G; Vali, R; Waldenberger, P; Stoiber, F; Nader, M; Gruy, B; Janetschek, G; Langsteger, W;
RADIOLOGY. 2010; 254(3): 925-933.
Originalarbeiten (Zeitschrift)
The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT
Beheshti, M; Vali, R; Waldenberger, P; Fitz, F; Nader, M; Hammer, J; Loidl, W; Pirich, C; Fogelman, I; Langsteger, W
MOL IMAGING BIOL. 2010; 12(1): 98-107.
Originalarbeiten (Zeitschrift)
[Online support groups for localized prostate cancer: qualitative analysis of decision making].
Huber, J; Peters, T; Kessler, A; Ihrig, A; Huber, CG; Hadaschik, B; Pahernik, S; Hohenfellner, M;
Urologe A. 2010; 49(11):1377-1384
Originalarbeiten (Zeitschrift)
Radiation therapy for prostate cancer in the new S3 guideline - Part 2: postoperative radiation therapy and brachytherapy
Martin, T; Wenz, F; Bohmer, D; Sedlmayer, F; Hinkelbein, W; Henkel, TO; Miller, K; Wiegel, T
UROLOGE. 2010; 49(2): 216-220.
Originalarbeiten (Zeitschrift)
Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy.
Mitterberger, M; Aigner, F; Pinggera, GM; Steiner, E; Rehder, P; Ulmer, H; Halpern, EJ; Horninger, W; Frauscher, F;
BJU Int. 2010; 106(9): 1315-1318.
Originalarbeiten (Zeitschrift)
Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia.
Mitterberger, M; Horninger, W; Aigner, F; Pinggera, GM; Rehder, P; Steiner, E; Wiunig, C; Reissigl, A; Frauscher, F;
BJU Int. 2010; 105(12): 1660-1662.
Originalarbeiten (Zeitschrift)
Ultrasound of the prostate.
Mitterberger, M; Horninger, W; Aigner, F; Pinggera, GM; Steppan, I; Rehder, P; Frauscher, F;
Cancer Imaging. 2010; 10: 40-48.
Übersichtsarbeiten
Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection.
Mitterberger, MJ; Aigner, F; Horninger, W; Ulmer, H; Cavuto, S; Halpern, EJ; Frauscher, F;
Eur Radiol. 2010; 20(12): 2791-2796.
Originalarbeiten (Zeitschrift)
Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis.
Stanzer, S; Balic, M; Strutz, J; Heitzer, E; Obermair, F; Hauser-Kronberger, C; Samonigg, H; Dandachi, N;
CLIN BIOCHEM. 2010; 43(18): 1443-1448.
Originalarbeiten (Zeitschrift)
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer
Warmuth, M; Johansson, T; Mad, P
EUR UROL. 2010; 58(6): 803-815.
Übersichtsarbeiten
The German S3 guideline prostate cancer: aspects for the radiation oncologist.
Wenz, F; Martin, T; Böhmer, D; Martens, S; Sedlmayer, F; Wirth, M; Miller, K; Heidenreich, A; Schrader, M; Hinkelbein, W; Wiegel, T;
STRAHLENTHER ONKOL. 2010; 186(10): 531-534.
Originalarbeiten (Zeitschrift)
Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate.
Aigner, F; Pallwein, L; Mitterberger, M; Pinggera, GM; Mikuz, G; Horninger, W; Frauscher, F;
BJU Int. 2009; 103(4): 458-463.
Originalarbeiten (Zeitschrift)
The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.
Beheshti, M; Vali, R; Waldenberger, P; Fitz, F; Nader, M; Hammer, J; Loidl, W; Pirich, C; Fogelman, I; Langsteger, W;
MOL IMAGING BIOL. 2009; 11(6): 446-454.
Originalarbeiten (Zeitschrift)
[Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer].
Gillitzer, R; Hampel, C; Thomas, C; Schmidt, F; Melchior, SW; Pahernik, S; Schmidberger, H; Thuroff, JW
Urologe A. 2009; 48(4):399-407
Originalarbeiten (Zeitschrift)
[Androgens stimulate the expression of SOCS-3 and inhibits their effect on proliferation and secretion].
Neuwirt, H; Puhr, M; Cavarretta, IT; Mitterberger, M; Hobisch, A; Culig, Z;
Aktuelle Urol. 2009; 40(4): 231-234.
Originalarbeiten (Zeitschrift)
Survival in prostate cancer patients > or = 70 years after radical prostatectomy and comparison to younger patients.
Pfitzenmaier, J; Pahernik, S; Buse, S; Haferkamp, A; Djakovic, N; Hohenfellner, M
World J Urol. 2009; 27(5):637-642
Originalarbeiten (Zeitschrift)
Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
Pfitzenmaier, J; Pritsch, M; Haferkamp, A; Jakobi, H; Fritsch, F; Gilfrich, C; Djakovic, N; Buse, S; Pahernik, S; Hohenfellner, M
BJU Int. 2009; 103(7):877-882
Originalarbeiten (Zeitschrift)
Postoperative radiotherapy for advanced prostate cancer: improved local control translates into increased survival.
Sautter-Bihl, ML; Sedlmayer, F; Wiegel, T;
STRAHLENTHER ONKOL. 2009; 185(8): 485-487.
Editorials
Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich, E; Schally, AV; Buchholz, S; Rick, FG; Halmos, G; Mile, M; Groot, K; Hohla, F; Zarandi, M; Varga, JL;
Prostate. 2008; 68(16):1763-1772
Originalarbeiten (Zeitschrift)
A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients.
Nairz, O; Merz, F; Deutschmann, H; Kopp, P; Schöller, H; Zehentmayr, F; Wurstbauer, K; Kametriser, G; Sedlmayer, F;
Strahlenther Onkol. 2008; 184(12):663-667
Originalarbeiten (Zeitschrift)
Ultrasound of prostate cancer: recent advances.
Pallwein, L; Mitterberger, M; Pelzer, A; Bartsch, G; Strasser, H; Pinggera, GM; Aigner, F; Gradl, J; Zur Nedden, D; Frauscher, F;
Eur Radiol. 2008; 18(4):707-715
Übersichtsarbeiten
Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients.
Pallwein, L; Mitterberger, M; Pinggera, G; Aigner, F; Pedross, F; Gradl, J; Pelzer, A; Bartsch, G; Frauscher, F;
Eur J Radiol. 2008; 65(2):304-310
Originalarbeiten (Zeitschrift)
Over-diagnosis and under-diagnosis of screen- vs non-screen-detected prostate cancers with in men with prostate-specific antigen levels of 2.0-10.0 ng/mL.
Pelzer, AE; Colleselli, D; Bektic, J; Schaefer, G; Ongarello, S; Schwentner, C; Aigner, F; Mitterberger, M; Steiner, E; Bartsch, G; Horninger, W;
BJU Int. 2008; 101(10): 1223-1226.
Originalarbeiten (Zeitschrift)
Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?
Pelzer, AE; Colleselli, D; Bektic, J; Steiner, E; Ramoner, R; Mitterberger, M; Schwentner, C; Schaefer, G; Ongarello, S; Bartsch, G; Horninger, W;
BJU Int. 2008; 101(7): 822-825.
Originalarbeiten (Zeitschrift)
Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
Pfitzenmaier, J; Pahernik, S; Tremmel, T; Haferkamp, A; Buse, S; Hohenfellner, M
BJU Int. 2008; 102(10):1413-1418
Originalarbeiten (Zeitschrift)
Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.
Secin, FP; Jiborn, T; Bjartell, AS; Fournier, G; Salomon, L; Abbou, CC; Haber, GP; Gill, IS; Crocitto, LE; Nelson, RA; Cansino Alcaide, JR; Martínez-Piñeiro, L; Cohen, MS; Tuerk, I; Schulman, C; Gianduzzo, T; Eden, C; Baumgartner, R; Smith, JA; Entezari, K; van Velthoven, R; Janetschek, G; Serio, AM; Vickers, AJ; Touijer, K; Guillonneau, B;
Eur Urol. 2008; 53(1): 13-45.
Originalarbeiten (Zeitschrift)
Comparison of lidocaine suppositories and periprostatic nerve block during transrectal prostate biopsy.
Szlauer, R; Gotschl, R; Gnad, A; Meissner, P; Paras, L; Schmeller, NT; Fink, KG
Urol Int. 2008; 80(3):253-256
Originalarbeiten (Zeitschrift)
The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy.
Colleselli, D; Bektic, J; Schaefer, G; Frauscher, F; Mitterberger, M; Brunner, A; Schwentner, C; Bartsch, G; Horninger, W; Pelzer, AE;
BJU Int. 2007; 100(6): 1264-1267.
Originalarbeiten (Zeitschrift)
Prostate biopsy in Central Europe: results of a survey of indication, patient preparation and biopsy technique.
Fink, KG; Schmid, HP; Paras, L; Schmeller, NT
UROL INT. 2007; 79(1): 60-66.
Originalarbeiten (Zeitschrift)
The association between local atherosclerosis and prostate cancer.
Hager, M; Mikuz, G; Bartsch, G; Kolbitsch, C; Moser, PL;
BJU INT. 2007; 99(1): 46-48.
Originalarbeiten (Zeitschrift)
A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection.
Mitterberger, M; Horninger, W; Pelzer, A; Strasser, H; Bartsch, G; Moser, P; Halpern, EJ; Gradl, J; Aigner, F; Pallwein, L; Frauscher, F;
Prostate. 2007; 67(14):1537-1542
Originalarbeiten (Zeitschrift)
Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer.
Pallwein, L; Mitterberger, M; Gradl, J; Aigner, F; Horninger, W; Strasser, H; Bartsch, G; zur Nedden, D; Frauscher, F;
Curr Opin Urol. 2007; 17(1):39-47
Übersichtsarbeiten
Real-time elastography for detecting prostate cancer: preliminary experience.
Pallwein, L; Mitterberger, M; Struve, P; Pinggera, G; Horninger, W; Bartsch, G; Aigner, F; Lorenz, A; Pedross, F; Frauscher, F;
BJU Int. 2007; 100(1):42-46
Originalarbeiten (Zeitschrift)
Diagnostic work-up of bone metastases of genitourinary tumors and their treatment with bisphosphonates. Interdisciplinary consensus conference, Frankfurt, 2006
Schlimok, G; Wilhelm, M; Weissbach, L
ONKOLOGE. 2007; 13(1): 77-80.
Originalarbeiten (Zeitschrift)
Technology insight: radioguided sentinel lymph node dissection in the staging of prostate cancer.
Beri, A; Janetschek, G;
Nat Clin Pract Urol. 2006; 3(11): 602-610.
Übersichtsarbeiten
[Urethroplasty and simultaneous perineal prostatectomy after traumatic urethral disruption and carcinoma of the prostate].
Gillitzer, R; Hampel, C; Pahernik, S; Melchior, SW; Thuroff, JW
UROLOGE. 2006; 45(9): 1181-1183.
Fallberichte
Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7.
Mian, C; Lodde, M; Comploj, E; Palermo, S; Lusuardi, L; Marziani, F; Chiocchetti, A; Spada, A; Mian, M; Pycha, A;
Prostate. 2006; 66(9): 966-970.
Originalarbeiten (Zeitschrift)
Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working Group.
Rassweiler, J; Stolzenburg, J; Sulser, T; Deger, S; Zumbé, J; Hofmockel, G; John, H; Janetschek, G; Fehr, JL; Hatzinger, M; Probst, M; Rothenberger, KH; Poulakis, V; Truss, M; Popken, G; Westphal, J; Alles, U; Fornara, P;
Eur Urol. 2006; 49(1): 113-119.
Originalarbeiten (Zeitschrift)
Prostate biopsy outcome using 29 mm cutting length.
Fink, KG; Hutarew, G; Pytel, A; Schmeller, NT;
UROL INT. 2005; 75(3): 209-212.
Originalarbeiten (Zeitschrift)
Cellular retinoic acid-binding protein 2 is down-regulated in prostate cancer
Okuducu, AF; Janzen, V; Ko, Y; Hahne, JC; Lu, H; Ma, ZL; Albers, P; Sahin, A; Wellmann, A; Scheinert, P; Wernert, N
INT J ONCOL. 2005; 27(5): 1273-1282.
Originalarbeiten (Zeitschrift)
One 10-core prostate biopsy is superior to two sets of sextant prostate biopsies.
Fink, KG; Hutarew, G; Pytel, A; Esterbauer, B; Jungwirth, A; Dietze, O; Schmeller, NT;
BJU INT. 2003; 92(4): 385-388.
Originalarbeiten (Zeitschrift)
Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
Djavan, B; Mazal, P; Zlotta, A; Wammack, R; Ravery, V; Remzi, M; Susani, M; Borkowski, A; Hruby, S; Boccon-Gibod, L; Schulman, CC; Marberger, M;
Prostate. 2001; 47(2): 111-117.
Originalarbeiten (Zeitschrift)
Costs of standard and conformal photon radiotherapy in Austria.
Hohenberg, G; Sedlmayer, F;
Strahlenther Onkol. 1999; 175 Suppl 2: 99-101.
Originalarbeiten (Zeitschrift)
Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images.
White, S; Hricak, H; Forstner, R; Kurhanewicz, J; Vigneron, DB; Zaloudek, CJ; Weiss, JM; Narayan, P; Carroll, PR;
Radiology. 1995; 195(2):385-390
Originalarbeiten (Zeitschrift)